pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
mRNA Therapeutic · news · pharmadog
← back to mRNA Therapeutic
News · mRNA Therapeutic
232
stories
Aug 27, 26
STAT+: The mystery of Moderna’s magic algorithm
stat
Aug 27, 26
CAR Ts will only treat autoimmune diseases if we can scale delivery
biospace
Aug 26, 26
Capricor’s DMD therapy still alive, Merck/Moderna’s cancer vax shines, FDA’s future revealed
biospace
Aug 25, 26
STAT+: How Trump’s funding cuts are reshaping the health system
stat
Aug 25, 26
With mRNA back in the spotlight, tRNA shows potential to treat genetic disease
fiercebiotech
Aug 25, 26
STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more
stat
Aug 24, 26
STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
stat
Aug 24, 26
STAT+: Inside Moderna and Merck’s cancer vaccine triumph
stat
Aug 24, 26
Capricor, Replimune reviews signal FDA’s return to reliability but every application will stand alone
biospace
Aug 21, 26
Capricor investor calls for change as company awaits decision on Duchenne candidate
biospace
Aug 21, 26
STAT+: HHS document offers new clues to Kennedy’s vaccine plans
stat
Aug 21, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
Aug 21, 26
STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more
stat
Aug 21, 26
Shareholder pressures Capricor; Lilly dives deeper into vaccines
biopharma dive
Aug 20, 26
STAT+: FDA approves Ultragenyx gene therapy
stat
Aug 20, 26
Contrasting legal decisions on gender-affirming care
stat
Aug 20, 26
STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
stat
Aug 20, 26
Merck’s Moderna-partnered vaccine success clears view of post-Keytruda future
biospace
Aug 20, 26
STAT+: One of the most consequential years for cancer treatment, ever
stat
Aug 20, 26
Merck-Moderna cancer vaccine win spurs stock jump, speculation of Keytruda-like impact
fiercebiotech
Aug 20, 26
Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study
stat
Aug 20, 26
7 biopharma M&A deals where layoffs followed
biospace
Aug 19, 26
Trump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: Analysts
biospace
Aug 19, 26
STAT+: Experts scrutinize Huidagene’s disclosures after patient death
stat
Aug 19, 26
STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval
stat
Aug 19, 26
STAT+: American Cancer Society cancels alcohol industry fundraiser
stat
Aug 19, 26
STAT+: Brain organoids, kept alive more than five years, matured like human brains
stat
Aug 19, 26
Moderna stock nearly doubles as Merck-partnered mRNA cancer vaccine meets Phase 3 goal
biospace
Aug 19, 26
STAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and more
stat
Aug 19, 26
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
biopharma dive
← prev
page 5 of 8
next →